Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-28 @ 12:58 PM
Study NCT ID:
NCT01312961
Status:
COMPLETED
Last Update Posted:
2017-06-08
First Post:
2011-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-09
First Submit QC Date:
None
Study First Post Date:
2011-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-04-27
Results First Submit QC Date:
None
Results First Post Date:
2017-06-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-02-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-06-07
Last Update Post Date:
2017-06-08
Last Update Post Date Type:
ACTUAL